Trial intelligence / Profile preview

Continuous vs Single Shot Interscalene Block for Shoulder Replacement

NCT02267044Completed

Sponsor
TriHealth
Start
Aug 2014
Primary completion
Oct 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of ropivacaine in postoperative pain, sponsored by TriHealth. Primary endpoint: Pain Score at 3 days. Started Aug 2014; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02267044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02267044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call